Foundation Medicine, WuXi PharmaTech deal

Foundation Medicine will grant WuXi non-exclusive rights to offer Foundation Medicine's FoundationOne assay for profiling genomic alterations in solid tumors in China. WuXi's Genome Center in Shangha...